Beijing Med-Pharm Corp.

Mr. Powell has served as BMP Sunstone’s Chief Financial Officer since January 2005. And prior to this, he had been with Eximias Pharmaceutical Corporation as the CFO since May 2002. He was Senior Vice President, Finance and Administration, at InnaPhase where he was mainly responsible for all financial, internal control, HR, administrative, and legal affairs. At Premier Research Worldwide (PRWW), Mr. Powell served as CFO and helped PRWW become one of the nation’s leading clinical research organizations by leading the Company’s initial public offering and managing several acquisitions, including DLB, a clinical trial and data management software company. From 1983 to 1989, Mr. Powell spent seven years at KPMG Peat Marwick as a Senior Manager responsible for directing the planning, coordination and deliver of audit management and technology services to clients in the pharmaceutical and services industries. Mr. Powell graduated from Penn State University in 1983, with a Bachelor of Sciences in Accounting and is a Certified Public Accountant.

Ms. Zhao has served as BMP Sunstone’s Corporate Vice President since October 2007. From 1992 until 2007, Ms. Zhao held various senior positions with Sino Biopharmaceutical Ltd, where she held senior posts of Vice President and Executive Director in the Corporation, Executive Director in Shandong Chia Tai Freda Pharmaceutical Ltd, as well as Managing Director of its subsidiaries. Ms. Zhao also served as Department Head at Inner Mongolia Medicine and Health Products Import Export Corporation, and Deputy Plan Manager at Inner Mongolia Yuanbaoshan Pharmaceutical Ltd during 1983 to 1992. Ms. Zhao has a Pharmaceutical degree from Shenyang Pharmaceutical University and a MBA from Dalian University of Technology.

Since July 2004, Mr. Greenacre has served as Chairman of Beijing Med-Pharm Corporation, a pharmaceutical company. Mr. Greenacre also has served since 2002 as Chairman of Life Mist Technologies, Inc., a fire suppression equipment company. From 1997 to 2001, Mr. Greenacre served as Chief Executive Officer and director of Delsys Pharmaceutical Corporation, a formulation and drug delivery system company. From 1993 to 1997, Mr.

John W. Stakes III, M.D., has served as one of our directors since February 2004. Dr. Stakes has served as an Associate Neurologist at Massachusetts General Hospital since 1990, as Director, Massachusetts General Hospital Sleep Disorders Laboratory, since 1982, and as Director, Specialty Care Development, Massachusetts General Physicians Organization, since 1995. He was a member of the Committee on Continuing Medical Education of the Harvard Medical School. Dr. Stakes has held a teaching position at the Harvard Medical School since 1975.